Literature DB >> 2164140

Nifedipine administration impairs natural resistance of mice to Salmonella typhimurium.

K Nalini1, K I Andrabi, N K Ganguly, P L Wahi.   

Abstract

Administration of Ca2+ channel blockers in cardiac disorders and the central role of Ca2+ in modulating neutrophil functions, prompted us to investigate whether administration of nifedipine to mice would alter their natural resistance to infectious agents like Salmonella typhimurium. Neutrophil chemiluminescence (CL) in response to S. typhimurium was significantly (p less than 0.01) decreased in mice fed with nifedipine (0.015 mg/kg body weight) over a period of six months. Intracellular killing of S. typhimurium by isolated neutrophils also decreased significantly (p less than 0.01) and exponentially with nifedipine administration, representing a 42% fall at six months. In addition the drug administration lowered the survival rate of animals following challenge by a lethal dose of S. typhimurium (LD50 = 1 x 10(4) bacteria/animal). Our data suggest that long term administration of nifedipine lowers the natural resistance of mice to S. typhimurium owing to impaired neutrophil functions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164140     DOI: 10.1007/BF00219971

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  The effect of verapamil and other calcium antagonists on chemotaxis of polymorphonuclear leukocytes.

Authors:  J G Elferink; M Deierkauf
Journal:  Biochem Pharmacol       Date:  1984-01-01       Impact factor: 5.858

Review 2.  Mechanism of action of calcium-channel-blocking agents.

Authors:  E Braunwald
Journal:  N Engl J Med       Date:  1982-12-23       Impact factor: 91.245

3.  Influence of drugs that block calcium channels on the microbicidal function of human neutrophils.

Authors:  P H Kazanjian; J E Pennington
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

4.  Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.

Authors:  H Glossmann; D R Ferry; A Goll; M Rombusch
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

5.  Luminol-dependent chemiluminescence produced by neutrophils stimulated by immune complexes.

Authors:  K Cheung; A C Archibald; M F Robinson
Journal:  Aust J Exp Biol Med Sci       Date:  1984-08

6.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

7.  Chemiluminescent response to pathogenic organisms: normal human polymorphonuclear leukocytes.

Authors:  P Robinson; D Wakefield; S N Breit; J F Easter; R Penny
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

8.  Verapamil impairs human neutrophil chemotaxis by a non-calcium-mediated mechanism.

Authors:  J E Pennington; B Kemmerich; P H Kazanjian; J D Marsh; L W Boerth
Journal:  J Lab Clin Med       Date:  1986-07

9.  Mono- and dihydroxyeicosatetraenoic acids alter calcium homeostasis in rabbit neutrophils.

Authors:  P H Naccache; R I Sha'afi; P Borgeat; E J Goetzl
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes.

Authors:  J G Elferink
Journal:  Arzneimittelforschung       Date:  1982
View more
  1 in total

1.  Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis.

Authors:  Sabine M Mair; Manfred Nairz; Rosa Bellmann-Weiler; Thomas Muehlbacher; Andrea Schroll; Igor Theurl; Patrizia L Moser; Heribert Talasz; Ferric C Fang; Guenter Weiss
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.